... for an IPO: its revenue in 2023 amounted to 32.5 billion rubles, and the company's strategists emphasize growing investor interest in Russian pharmaceutical assets. Another example is “Ozon Pharmaceuticals”—a generic manufacturer from the Samara region—that announced IPO plans for the fall of 2024. In the narrower biotech segment, companies like “Betuvax” (vaccine “Betuvax-CoV-2”) and “Promomed” are mentioned; although they are more focused on biopharmaceuticals, their IPOs demonstrate ...

... increase suggests economic recovery, benefiting the euro, whereas a slowdown may raise concerns about a Eurozone recession. 13:00 MSK: Eurozone — Q3 2024 GDP The Eurozone's Gross Domestic Product data for the third quarter will provide insights into the region's economic recovery pace. Positive figures could bolster the euro and market optimism, while weak data might exert pressure on the currency and dampen market sentiment. 16:30 MSK: USA — Nonfarm Payrolls Report for November The Nonfarm Payrolls ...

... facilities (UGS) in the EU are filled to over 85%, providing a buffer ahead of winter and keeping prices at a moderate level. Meanwhile, the global energy transition is gaining momentum, with new records for renewable energy generation being set in many regions, although countries have not entirely abandoned traditional resources for energy system reliability. In Russia, following a recent surge in prices, authorities are implementing a comprehensive set of measures aimed at stabilizing the situation ...

... indices for industrial activity in major European economies — Germany, France, the entire Eurozone, and the **United Kingdom** — will be published throughout the day. Preliminary July PMIs indicated a continued decline in manufacturing activity in the region, although the pace of contraction may have slightly eased. These macroeconomic developments are vital for assessing the state of the European economy and the prospects of the industrial sector. **Switzerland** will be closed for trading on Friday ...

... the core gas business in the domestic market and Asia. The growth in ruble revenue is primarily driven by the gas segment, compensating for declines in some other areas. This reflects the company's adaptation to new realities: gas exports to distant regions have quantitatively decreased, but the currency revenues converted into rubles are supported by the exchange rate, and domestic sales remain a solid revenue base. Expenditure and Profitability: Tax Change Effects In the first half of 2025, Gazprom's ...